Article 1
The substances indicated in the Annex to this Decision shall not be included for the product-types concerned in Annex I, IA or IB to Directive 98/8/EC.
2013/85/EU: Commission Decision of 14 February 2013 concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (notified under document C(2013) 670) Text with EEA relevance
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The substances indicated in the Annex to this Decision shall not be included for the product-types concerned in Annex I, IA or IB to Directive 98/8/EC.
For the purposes of Article 4(2) of Regulation (EC) No 1451/2007, biocidal products of the product-types listed in the Annex to this Decision which contain the active substances listed in that Annex shall no longer be placed on the market with effect from 1 February 2014.
This Decision is addressed to the Member States.
ANNEX Substances and product-types not to be included in Annex I, IA or IB to Directive 98/8/EC Name EC number CAS number Product-type Rapporteur Member State Glutaral 203-856-5 111-30-8 5 FI 4-(2-nitrobutyl)morpholine 218-748-3 2224-44-4 6 UK 4-(2-nitrobutyl)morpholine 218-748-3 2224-44-4 13 UK N,N’-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride 274-861-8 70775-75-6 1 HU Salicylic acid 200-712-3 69-72-7 1 NL
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.